Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

But in the wake of the COVID-19 pandemic, there is an even greater ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting ...

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

The world is waiting with bated breath for a coronavirus vaccine, which has become one of the most sought-after pharmaceutical products of the last century. The hope is that a vaccine can stop the ...

Pfizer (PFE) reported its third-quarter earnings on Tuesday, beating Wall Street expectations and its raising its full-year ...

Increasingly, injectable manufacturers recognise that to achieve maximum profitability, they need to focus on the value they ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations that it misused a patented protein while testing a COVID-19 treatment. Law firm Crowell & Moring ...

Other pharmaceutical companies may follow suit ... PfizerForAll targets patients seeking care for migraines, Covid-19 or influenza, in addition to vaccines for Covid-19, flu, respiratory syncytial ...

The stocks of drugmakers with other successful products are less risky ... wasn't a major player in the COVID-19 vaccine market. However, the big pharmaceutical company has 18 other approved ...

Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and stand-alone flu inoculation, sending shares down sharply. The vaccine ...